scispace - formally typeset
S

Sabine E. Mous

Researcher at Erasmus University Rotterdam

Publications -  25
Citations -  963

Sabine E. Mous is an academic researcher from Erasmus University Rotterdam. The author has contributed to research in topics: Population & Autism. The author has an hindex of 13, co-authored 23 publications receiving 680 citations. Previous affiliations of Sabine E. Mous include Boston Children's Hospital.

Papers
More filters
Journal ArticleDOI

What Twin Studies Tell Us About the Heritability of Brain Development, Morphology, and Function: A Review

TL;DR: An overview of twin studies using MRI in children, adults and elderly and focuses on cross-sectional and longitudinal designs suggests that the heritability of change over time is relatively low or absent, but more studies are needed to confirm these findings.
Journal ArticleDOI

Genome-wide association studies of a broad spectrum of antisocial behavior

Jorim J. Tielbeek, +53 more
- 01 Dec 2017 - 
TL;DR: The Broad Antisocial Behavior Consortium entails the largest collaboration to date on the genetic architecture of ASB, and the first results suggest that ASB may be highly polygenic and has potential heterogeneous genetic effects across sex.
Journal ArticleDOI

Paediatric population neuroimaging and the Generation R Study: the second wave

TL;DR: An overview of the imaging protocol and the overlap between the neuroimaging data and metadata is provided, which highlights a diverse array of questions that can be addressed by merging the fields of developmental neuroscience and epidemiology.
Journal ArticleDOI

White matter integrity and cognitive performance in school-age children: A population-based neuroimaging study.

TL;DR: Results demonstrate white matter structure-function associations are present in children, independent of age and broader cognitive abilities, and the presence of such associations in the general population is informative for studies examining child psychopathology.
Journal ArticleDOI

A randomized controlled trial with everolimus for IQ and autism in tuberous sclerosis complex.

TL;DR: This study provides Class I evidence that for children with TSC, everolimus does not improve intellectual disability, autism, behavioral problems, or other neuropsychological deficits and should not be encouraged in this age group.